诱发性高血压治疗动脉瘤性蛛网膜下腔出血后迟发性脑缺血:德国全国性调查
共60/132个科室(45%)回复,56/59个科室(95%)使用IH,主要在疑似DCI患者中(52/59,88%);MAP导向治疗最常用(64%),但各科室血流动力学目标差异很大;去甲肾上腺素是IH的主要升压药(98%);TCD是DCI检测的主要监测手段(93%);CT灌注(88%)和CT血管成像(79%)是疑似DCI最常用的影像检查;IH单独(47%)或联合动脉内解痉(36%)是主要一线治疗。结论指出IH仍是德国DCI管理的核心组成部分,但各环节差异显著,反映缺乏标准化循证治疗方案。
要点
- 在德国参与aSAH治疗的科室中,95%(56/59)使用诱发性高血压(IH)管理DCI,主要针对疑似DCI患者(88%,52/59)。
- MAP导向治疗是最常用的IH策略(64%),但各科室血流动力学目标差异很大;去甲肾上腺素是主要升压药(98%)。
- TCD是DCI检测的主要监测手段(93%),高级神经监测技术使用较少;CT灌注(88%)和CT血管成像(79%)是疑似DCI最常用影像。
- IH单独(47%)或联合动脉内解痉(36%)是主要一线治疗策略。
- 各中心在血流动力学目标、监测策略、影像方案和治疗策略上存在显著差异,提示缺乏标准化循证方案。
适用人群与场景
- 德国参与动脉瘤性蛛网膜下腔出血(aSAH)治疗的神经内科和神经外科科室,调查对象为各机构层面的临床实践。
- IH主要用于疑似迟发性脑缺血(DCI)的患者(52/59,88%)。
诊断标准与关键阈值
- 原文未提及
处置流程与药物剂量
- IH策略:MAP导向治疗最常用(64%),但各科室血流动力学目标差异很大;去甲肾上腺素是主要升压药(98%)。
- DCI检测:经颅多普勒(TCD)超声是主要监测手段(93%),高级神经监测技术使用较少。
- 疑似DCI影像:CT灌注(88%)和CT血管成像(79%)是最常用方式。
- 一线治疗:IH单独(47%)或联合动脉内解痉(36%)为主要策略。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 样本量与中心数:60/132个科室(45%)回复;IH使用率为56/59(95%);疑似DCI患者中使用IH为52/59(88%)。
- 主要结果:MAP导向IH策略占64%;去甲肾上腺素占98%;TCD监测占93%;CT灌注占88%;CT血管成像占79%;IH单独一线治疗占47%,联合动脉内解痉占36%。
- 关键发现:各科室在血流动力学目标、监测策略、影像方案和治疗策略上存在显著差异。
证据类型、等级与局限
- 证据类型:全国性横断面调查(专家意见/临床实践模式调查),非RCT或系统评价。
- 证据等级或推荐强度:原文未给出正式证据等级或推荐强度。
- 局限:原文指出当前实践主要基于观察性证据且指南推荐不一致;调查回复率45%(60/132),可能存在无应答偏倚;调查仅反映德国情况。
对床旁实践的改变
- 该调查反映德国多数中心(95%)在疑似DCI的aSAH患者中使用IH,以MAP为导向、去甲肾上腺素为主要升压药,但目标值高度不一,提示床旁实施IH时需个体化并注意本机构方案差异。
- TCD(93%)和CT灌注(88%)是DCI检测与影像评估的主要手段,可参考作为床旁监测与影像选择依据。
- IH单独或联合动脉内解痉是主要一线策略,但原文未提供标准化方案,不能据此推导具体血压目标或药物剂量推荐。
指南或共识出处
- Induced Hypertension for Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage-A German Nationwide Survey(Neurocrit Care),德国全国性调查,2025年。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Delayed cerebral ischemia (DCI) remains a major cause of morbidity after aneurysmal subarachnoid hemorrhage (aSAH). Induced hypertension (IH) is frequently used to improve cerebral perfusion in patients with DCI, with current practice primarily supported by observational evidence with inconsistent guideline recommendations. We conducted a nationwide survey to assess current institutional approaches to IH in the management of DCI after aSAH in Germany.
METHODS: An 11-item web-based questionnaire was distributed via LimeSurvey® between May and October 2025 to neurological and neurosurgical departments in Germany involved in the treatment of aSAH. The survey assessed institutional approaches to IH, monitoring and imaging strategies, and DCI treatment.
RESULTS: Overall, 60/132 departments (45%) responded. IH was used by 56/59 departments (95%), predominantly in patients with suspected DCI (52/59, 88%). MAP-guided therapy was the most commonly applied IH strategy (64%), although hemodynamic targets varied substantially between departments. Noradrenaline was the primary vasopressor used for IH (98%). Transcranial doppler (TCD) ultrasonography was the predominant monitoring modality for DCI detection (93%), whereas advanced neuromonitoring techniques were used less frequently. Computed tomography (CT) perfusion (88%) and CT angiography (79%) were the most commonly applied imaging modalities in suspected DCI. IH alone (47%) or combined with intraarterial spasmolysis (36%) represented the leading first-line therapeutic approaches.
CONCLUSIONS: IH remains a central component of DCI management after aSAH in Germany. Considerable variability regarding hemodynamic targets, monitoring strategies, imaging protocols, and therapeutic strategies highlights the absence of standardized evidence-based treatment approaches.
参考来源
- Kranawetter B, Hernández-Durán S, Abboud T, et al. Induced Hypertension for Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage-A German Nationwide Survey. Neurocrit Care. 2026. PMID: 42625003. doi:10.1007/s12028-026-02635-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。